RESTON, Va., June 22, 2020 /PRNewswire/ -- Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, was awarded a new contract by the Department of Veterans Affairs (VA) to design and implement a regional consolidated mail outpatient pharmacy system (CMOP). The standard contract holds a total approximate value of $79 million and includes a two-year period of performance followed by 20 three-month option periods. Work will be performed in Shawnee, Kan.
"We are excited to build on our six-year legacy supporting the VA's national pharmacy systems," said Debbie Opiekun, Leidos Military and Veterans Health Solutions senior vice president. "This contract accelerates the VA's mission to modernize their pharmacy infrastructure through an integrated, automated pharmacy system with cutting-edge technology and superior integration services. Leidos looks forward to enabling VA CMOPs to achieve their growth goals, meet patient safety requirements, and maintain extremely high quality."
Leidos will establish a new, state-of-the-art CMOP for the VA to replace its legacy Leavenworth, Kan. facility. The company will provide a highly-automated capability that uses robotic devices and conveyor systems to accurately fill and ship more than 80,000 prescriptions per day for U.S. military veterans and other eligible patients. The Leidos team will build and maintain an end-to-end automated prescription fulfillment system that provides reliable production processes, increased efficiencies of scale, and robust platforms for future use.
This release does not, in any respect, state or imply the Department of Veterans Affairs' approval or endorsement of Leidos' products or services nor does it state or imply that the Department of Veterans Affairs considers Leidos' products or services superior to other products or services.
Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 37,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Va., Leidos reported annual revenues of approximately $11.09 billion for the fiscal year ended January 3, 2020. For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended January 3, 2020, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.